These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 16596198

  • 21. Aberrant methylation of IL-12Rbeta2 gene in lung adenocarcinoma cells is associated with unfavorable prognosis.
    Suzuki M, Iizasa T, Nakajima T, Kubo R, Iyoda A, Hiroshima K, Nakatani Y, Fujisawa T.
    Ann Surg Oncol; 2007 Sep; 14(9):2636-42. PubMed ID: 17602269
    [Abstract] [Full Text] [Related]

  • 22. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer.
    Kikuchi S, Yamada D, Fukami T, Masuda M, Sakurai-Yageta M, Williams YN, Maruyama T, Asamura H, Matsuno Y, Onizuka M, Murakami Y.
    Clin Cancer Res; 2005 Apr 15; 11(8):2954-61. PubMed ID: 15837747
    [Abstract] [Full Text] [Related]

  • 23. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S, Fields CR, Su N, Pan YX, Robertson KD.
    Oncogene; 2007 Apr 19; 26(18):2621-34. PubMed ID: 17043644
    [Abstract] [Full Text] [Related]

  • 24. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.
    Grote HJ, Schmiemann V, Geddert H, Bocking A, Kappes R, Gabbert HE, Sarbia M.
    Cancer; 2006 Apr 25; 108(2):129-34. PubMed ID: 16444703
    [Abstract] [Full Text] [Related]

  • 25. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
    Honorio S, Agathanggelou A, Schuermann M, Pankow W, Viacava P, Maher ER, Latif F.
    Oncogene; 2003 Jan 09; 22(1):147-50. PubMed ID: 12527916
    [Abstract] [Full Text] [Related]

  • 26. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer.
    Liu Z, Zhao J, Chen XF, Li W, Liu R, Lei Z, Liu X, Peng X, Xu K, Chen J, Liu H, Zhou QH, Zhang HT.
    Lung Cancer; 2008 Oct 09; 62(1):15-22. PubMed ID: 18358560
    [Abstract] [Full Text] [Related]

  • 27. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.
    Ito M, Ito G, Kondo M, Uchiyama M, Fukui T, Mori S, Yoshioka H, Ueda Y, Shimokata K, Sekido Y.
    Cancer Lett; 2005 Jul 08; 225(1):131-9. PubMed ID: 15922865
    [Abstract] [Full Text] [Related]

  • 28. CpG island methylation and expression of tumour-associated genes in lung carcinoma.
    Dammann R, Strunnikova M, Schagdarsurengin U, Rastetter M, Papritz M, Hattenhorst UE, Hofmann HS, Silber RE, Burdach S, Hansen G.
    Eur J Cancer; 2005 May 08; 41(8):1223-36. PubMed ID: 15911247
    [Abstract] [Full Text] [Related]

  • 29. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S, Sugio K, Uramoto H, Oyama T, Hanagiri T, Morita M, Yasumoto K.
    Cancer; 2006 May 15; 106(10):2190-9. PubMed ID: 16598757
    [Abstract] [Full Text] [Related]

  • 30. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D, Agathanggelou A, Honorio S, Dallol A, Martinsson T, Kogner P, Cummins C, Neumann HP, Voutilainen R, Dahia P, Eng C, Maher ER, Latif F.
    Oncogene; 2001 Nov 08; 20(51):7573-7. PubMed ID: 11709729
    [Abstract] [Full Text] [Related]

  • 31. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas.
    Kobatake T, Yano M, Toyooka S, Tsukuda K, Dote H, Kikuchi T, Toyota M, Ouchida M, Aoe M, Date H, Pass HI, Doihara H, Shimizu N.
    Oncol Rep; 2004 Nov 08; 12(5):1087-92. PubMed ID: 15492797
    [Abstract] [Full Text] [Related]

  • 32. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
    Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP.
    Nat Genet; 2000 Jul 08; 25(3):315-9. PubMed ID: 10888881
    [Abstract] [Full Text] [Related]

  • 33. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
    Wong ML, Tao Q, Fu L, Wong KY, Qiu GH, Law FB, Tin PC, Cheung WL, Lee PY, Tang JC, Tsao GS, Lam KY, Law S, Wong J, Srivastava G.
    Int J Oncol; 2006 Mar 08; 28(3):767-73. PubMed ID: 16465383
    [Abstract] [Full Text] [Related]

  • 34. Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer.
    Wang J, Lee JJ, Wang L, Liu DD, Lu C, Fan YH, Hong WK, Mao L.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6119-25. PubMed ID: 15447998
    [Abstract] [Full Text] [Related]

  • 35. Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features.
    Kim DS, Kim MJ, Lee JY, Lee SM, Choi JY, Yoon GS, Na YK, Hong HS, Kim SG, Choi JE, Lee SY, Park JY.
    Mol Carcinog; 2009 Dec 15; 48(12):1109-15. PubMed ID: 19554572
    [Abstract] [Full Text] [Related]

  • 36. Relationship of Ras association domain family 1 methylation and K-ras mutation in primary non-small cell lung cancer.
    Kim DH, Kim JS, Park JH, Lee SK, Ji YI, Kwon YM, Shim YM, Han J, Park J.
    Cancer Res; 2003 Oct 01; 63(19):6206-11. PubMed ID: 14559805
    [Abstract] [Full Text] [Related]

  • 37. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
    Wu JY, Wang J, Lai JC, Cheng YW, Yeh KT, Wu TC, Chen CY, Lee H.
    Ann Surg Oncol; 2008 Nov 01; 15(11):3272-7. PubMed ID: 18712569
    [Abstract] [Full Text] [Related]

  • 38. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.
    Zhang Y, Wang R, Song H, Huang G, Yi J, Zheng Y, Wang J, Chen L.
    Cancer Lett; 2011 Apr 01; 303(1):21-8. PubMed ID: 21255913
    [Abstract] [Full Text] [Related]

  • 39. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S, Yeo W, Tang MW, Wong N, Lai PB, Johnson PJ.
    Clin Cancer Res; 2003 Aug 15; 9(9):3376-82. PubMed ID: 12960125
    [Abstract] [Full Text] [Related]

  • 40. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
    Wang G, Hu X, Lu C, Su C, Luo S, Luo ZW.
    Lung Cancer; 2008 Nov 15; 62(2):162-72. PubMed ID: 18468719
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.